Review of Kidney Biopsies of Dent Disease Patients
Systematic Review of Clinical Biopsies of Dent Disease Patients
1 other identifier
observational
20
1 country
1
Brief Summary
This study is being done to obtain pathology reports from all patients in the Dent disease registry who have had a kidney biopsy. The investigator will collect the biopsy slides and reports in an attempt to determine if they have any common findings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 6, 2013
CompletedFirst Posted
Study publicly available on registry
December 27, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedSeptember 22, 2015
September 1, 2015
1.9 years
December 6, 2013
September 19, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biopsy changes
The primary outcome will be to determine the number of glomeruli, percent globally sclerotic glomeruli, percent focally sclerotic glomeruli, and the severity of interstitial fibrosis (none, mild, moderate, severe) and interstitial crystals (none, mild, moderate, severe)
2 years
Study Arms (1)
Dent Disease patients
Patients with diagnosed Dent Disease
Interventions
Eligibility Criteria
All patients in the Dent Registry with a previous renal biopsy
You may qualify if:
- All patients in the Dent Disease Registry with a previous renal biopsy.
You may not qualify if:
- None.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John C Lieske, M.D.
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
December 6, 2013
First Posted
December 27, 2013
Study Start
October 1, 2013
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
September 22, 2015
Record last verified: 2015-09